Circulating microparticles and endogenous estrogen in newly menopausal women

References

• Miller V M, Duckles S P. Vascular actions of estrogens: functional implications. Pharmacol Rev 2008; 60: 210–241
   PubMed Web of Science ®Google Scholar
• Pradhan A D, Manson J E, Rossouw J E, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. Prospective analysis from the Women's Health Initiative observational study. JAMA 2002; 288: 980–987
   PubMed Web of Science ®Google Scholar
• Ridker P M. C-reactive protein, inflammation, and cardiovascular disease. Clinical update. Curr Issues Cardiol 2005; 32: 384–386
   Google Scholar
• Andersson T, Flockhart D A, Goldstein D B, et al. Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests. Clin Pharmacol Ther 2005; 78: 559–581
   PubMed Web of Science ®Google Scholar
• Lynch S F, Ludlam C A. Plasma microparticles and vascular disorders. Br J Haematol 2007; 137: 36–48
   PubMed Web of Science ®Google Scholar
• Morel O, Toti F, Hugel B, et al. Procoagulant microparticles: disrupting the vascular homeostasis equation. Arterioscler Thromb Vasc Biol 2006; 26: 2594–2604
   PubMed Web of Science ®Google Scholar
• VanWijk M J, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003; 59: 277–287
   PubMed Web of Science ®Google Scholar
• Distler J H, Huber L C, Gay S, Distler O, Pisetsky D S. Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 2006; 39: 683–690
   PubMed Web of Science ®Google Scholar
• Berckmans R J, Neiuwland R, Boing A N, Romijn F P, Hack C E, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85: 639–646
   PubMed Web of Science ®Google Scholar
• Zwaal R F, Schroit A J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121–1132
   PubMed Web of Science ®Google Scholar
• Morel O, Toti F, Hugel B, Freyssinet J M. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 2004; 11: 156–164
   PubMedGoogle Scholar
• Jayachandran M, Litwiller R D, Owen W G, et al. Characterization of blood borne microparticles as markers of premature coronary calcification in recently menopausal women. Am J Physiol Heart Circ Physiol 2008; 295: 931–938
   PubMed Web of Science ®Google Scholar
• Boulanger C M, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006; 48: 180–186
   PubMed Web of Science ®Google Scholar
• Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G. Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26: 112–116
   PubMed Web of Science ®Google Scholar
• Pirro M, Schillaci G, Paltriccia R, et al. Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol 2006; 26: 2530–2535
   PubMed Web of Science ®Google Scholar
• Amabile N, Guerin A P, Leroyer A, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005; 16: 3381–3388
   PubMed Web of Science ®Google Scholar
• Harman S M, Brinton E A, Cedars M, et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric 2005; 8: 3–12
   PubMed Web of Science ®Google Scholar
• Smith R D, Owen W G. Platelet responses to compound interactions with thrombin. Biochemistry 1999; 38: 8936–8947
   PubMed Web of Science ®Google Scholar
• Jayachandran M, Mukherjee R, Steinkamp T, et al. Differential effects of 17β-estradiol, conjugated equine estrogen and raloxifene on mRNA expression, aggregation and secretion in platelets. Am J Physiol Heart Circ Physiol 2005; 288: H2355–H2362
   PubMed Web of Science ®Google Scholar
• Jayachandran M, Okano H, Chatrath R, Owen W G, McConnell J P, Miller V M. Sex-specific changes in platelet aggregation and secretion with sexual maturity in pigs. J Appl Physiol 2004; 97: 1445–1452
   PubMed Web of Science ®Google Scholar
• Jayachandran M, Brunn G J, Karnicki K, Miller R S, Owen W G, Miller V M. In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk. J Appl Physiol 2007; 102: 429–433
   PubMed Web of Science ®Google Scholar
• Aras O, Shet A, Bach R R, et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004; 103: 4545–4553
   PubMed Web of Science ®Google Scholar
• Nieuwland R, Berckmans R J, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95: 930–935
   PubMed Web of Science ®Google Scholar
• Shet A S, Aras O, Gupta K, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003; 102: 2678–2683
   PubMed Web of Science ®Google Scholar
• Biro E, Sturk-Maquelin K N, Vogel G M, et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003; 1: 2561–2568
   PubMed Web of Science ®Google Scholar
• Muller I, Klocke A, Alex M, et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J 2003; 17: 476–478
   PubMed Web of Science ®Google Scholar
• Suefuji H, Ogawa H, Yasue H, et al. Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J 1997; 134: 253–259
   PubMed Web of Science ®Google Scholar
• Soejima H, Ogawa H, Yasue H, et al. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation 1999; 99: 2908–2913
   PubMed Web of Science ®Google Scholar
• Wada H, Nakase T, Nakaya R, et al. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation. Am J Hematol 1994; 45: 232–236
   PubMed Web of Science ®Google Scholar
• Miller V M, Jayachandran M, Hashimoto K, Heit J A, Owen W G. Estrogen, inflammation, and platelet phenotype. Gender Med 2008; 5: S91–S102
   PubMed Web of Science ®Google Scholar
• Faraday N, Goldschmidt-Clermont P J, Bray P F. Gender differences in platelet GPIIb-IIIa activation. Thromb Haemost 1997; 77: 748–754
   PubMed Web of Science ®Google Scholar
• McBane R D, 2nd, Karnicki K, Miller R S, Owen W G. The impact of peripheral arterial disease on circulating platelets. Thromb Res 2004; 113: 137–145
   PubMed Web of Science ®Google Scholar
• McBane R D, 2nd, Karnicki K, Tahirkheli N, Miller R S, Owen W G. Platelet characteristics associated with coronary artery disease. J Thromb Haemost 2003; 1: 1296–1303
   PubMed Web of Science ®Google Scholar
• Christian R C, Harrington S, Edwards W D, Oberg A L, Fitzpatrick L A. Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women. J Clin Endocrinol Metab 2002; 87: 1062–1067
   PubMed Web of Science ®Google Scholar
• Hodis H N, Mack W J, Lobo R A, et al. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001; 135: 939–953
   PubMed Web of Science ®Google Scholar
• Slater C C, Zhang C, Hodis H N, et al. Comparison of estrogen and androgen levels after oral estrogen replacement therapy. J Reprod Med 2001; 46: 1052–1056
   PubMed Web of Science ®Google Scholar
• Karim R, Hodis H N, Stanczyk F Z, Lobo R A, Mack W J. Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab 2008; 93: 131–138
   PubMed Web of Science ®Google Scholar